智慧胰島素筆市場規模、佔有率、成長分析（按類型、易用性、產品類型、連接類型、適應症、最終用戶和地區分類）—產業預測（2026-2033年）

預計到 2024 年，智慧胰島素筆市場規模將達到 49.6 億美元，到 2025 年將成長至 54.7 億美元，到 2033 年將成長至 119.9 億美元，在預測期（2026-2033 年）內，複合年成長率為 10.3%。

智慧胰島素筆的出現，標誌著糖尿病管理領域的一項重大進步，它簡化了糖尿病患者體外注射胰島素的流程。這些創新設備具備及時提醒和警報功能，鼓勵患者規律用藥，並因其易用性而日益普及。智慧胰島素筆可與現有的胰島素輸注系統無縫連接，密切監測漏服劑量，確保劑量準確。透過定時血糖值監測、溫度控制和藥物有效期管理等功能，智慧胰島素筆得以維護詳細的糖尿病檔案，從而保障患者的健康。儘管外部因素對市場成長構成挑戰，但對便利高效的1型和第2型糖尿病管理解決方案的需求，仍持續推動智慧胰島素筆市場的擴張。

智慧胰島素筆市場促進因素

糖尿病患者人數的增加主要是由於現代社會的快速變化以及年輕一代日益沉重的負擔。患者人數的激增顯著提高了對胰島素產品的需求，其中智慧胰島素筆尤其備受關注。由於快節奏的生活方式使得血糖值控制和胰島素劑量調整變得困難，智慧技術已成為應對這些挑戰的有效解決方案。此外，人們對針刺傷的日益重視也進一步推動了對這些創新設備的需求，促使製造商擴大生產規模，以抓住這項盈利的市場機會。

限制智慧胰島素筆市場發展的因素

智慧胰島素筆的高昂價格可能會抑制其在全球市場的需求。在發展中地區，尤其是在非洲，許多病患由於醫療資源匱乏和報銷政策不合理而面臨許多挑戰。這些因素阻礙了他們獲得必要的醫療服務以及使用智慧胰島素筆等先進技術。因此，高成本加上支援不足，可能會對最需要這些創新設備的患者獲得和使用產生重大影響，最終阻礙市場成長，並限制糖尿病患者從中受益。

智慧胰島素筆市場趨勢

智慧胰島素筆市場正呈現顯著成長趨勢，這主要得益於醫療研發的不斷進步以及全球糖尿病患者數量的持續成長。隨著對創新型糖尿病管理解決方案的需求日益成長，製造商不斷推出旨在改善患者體驗並提高胰島素治療依從性的尖端產品。此外，連接性和劑量追蹤等技術的整合對於滿足糖尿病患者的複雜需求至關重要。這些技術創新，加上不斷成長的市場需求，為智慧胰島素筆市場創造了巨大的發展機遇，預計該市場在不久的將來將保持強勁成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球智慧胰島素筆市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 第一代筆
• 第二代筆

全球智慧型胰島素筆市場規模（依易用性及複合年成長率分類）（2026-2033 年）

• 預填充
• 可重複使用類型

全球智慧胰島素筆市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 智慧胰島素筆
• 傳統筆適配器

全球智慧胰島素筆市場規模（按連接類型和複合年成長率分類）（2026-2033 年）

• Bluetooth
• USB

全球智慧胰島素筆市場規模（按適應症和複合年成長率分類）（2026-2033 年）

• 1型糖尿病
• 2型糖尿病

全球智慧型胰島素筆市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院和診所
• 門診手術中心
• 居家醫療環境

全球智慧型胰島素筆市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（USA）
• Medtronic plc（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Ypsomed Holding AG（Switzerland）
• Companion Medical（USA）
• Digital Medics Pty Ltd（Australia）
• Biocorp（France）
• Emperra GmbH（USA）
• E-Health Technologies（Germany）
• Bigfoot Biomedical, Inc.（USA）
• Hoffmann-La Roche AG（Switzerland）
• Tandem Diabetes Care, Inc.（USA）
• Insulet Corporation（USA）
• Abbott Laboratories（USA）
• Terumo Corporation（Japan）
• Owen Mumford Ltd.（UK）
• SOOIL Development Co., Ltd.（South Korea）
• Pendiq GmbH（Germany）
• DarioHealth Corp.（Israel）

結論與建議

Smart Insulin Pens Market size was valued at USD 4.96 Billion in 2024 and is poised to grow from USD 5.47 Billion in 2025 to USD 11.99 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

Smart insulin pens represent a significant advancement in diabetes management by facilitating the external administration of insulin for diabetic patients. These innovative devices feature timely reminders and alerts that encourage regular dosing, enhancing usability and growing in popularity. Smart insulin pens can seamlessly attach to existing insulin delivery systems, providing critical monitoring of missed doses and ensuring accurate dosage administration. Their ability to maintain a detailed diabetes profile by tracking levels at designated times and ensuring temperature compliance and medication expiry safeguards patient health. Although there have been challenges affecting market growth due to external factors, the demand for convenient and efficient solutions in managing both type 1 and type 2 diabetes continues to propel the expansion of the smart insulin pen market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Insulin Pens Market Segments Analysis

Global Smart Insulin Pens Market is segmented by Type, Usability, Product, Connectivity Type, Indication, End User and region. Based on Type, the market is segmented into First Generation Pens and Second Generation Pens. Based on Usability, the market is segmented into Prefilled and Reusable. Based on Product, the market is segmented into Smart Insulin Pen and Adaptors for Conventional Pen. Based on Connectivity Type, the market is segmented into Bluetooth and USB. Based on Indication, the market is segmented into Type 1diabetesand Type 2 Diabetes. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Insulin Pens Market

The rise in the number of individuals with diabetes is largely attributed to the fast-paced nature of modern society and the increasing demands placed on younger generations. This surge in diabetic patients has led to a significant uptick in the demand for insulin products, among which smart insulin pens have gained notable popularity. As people's hectic lifestyles make it challenging to monitor diabetes readings and manage insulin dosing effectively, smart technology has emerged as a valuable solution to address these issues. Additionally, the growing awareness of needle stick injuries has further contributed to the demand for these innovative devices, prompting manufacturers to ramp up production in a bid to capitalize on this lucrative market opportunity.

Restraints in the Smart Insulin Pens Market

The elevated pricing of smart insulin pens is likely to hinder their demand in the global market. Many patients in developing regions, particularly in Africa, are facing challenges due to limited healthcare resources and unfavorable reimbursement policies. These conditions discourage individuals from pursuing necessary medical treatments or utilizing advanced technologies, like smart insulin pens. As a result, the combination of high costs and inadequate support systems may significantly impact the accessibility and adoption of these innovative devices for those who need them most, ultimately stymying market growth and limiting the benefits they offer to diabetic patients.

Market Trends of the Smart Insulin Pens Market

The smart insulin pens market is witnessing a significant trend driven by ongoing advancements in research and development within the healthcare sector, alongside the rising prevalence of diabetes globally. As the demand for innovative diabetes management solutions increases, manufacturers are launching cutting-edge products designed to enhance patient experience and adherence to insulin regimens. Furthermore, the integration of technology, such as connectivity features and dose tracking, is becoming essential in addressing the complex needs of diabetic patients. This convergence of innovation and growing market demand presents substantial opportunities for expansion, positioning the smart insulin pens market for robust growth in the foreseeable future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Smart Insulin Pens Market Size by Type & CAGR (2026-2033)

• Market Overview
• First Generation Pens
• Second Generation Pens

Global Smart Insulin Pens Market Size by Usability & CAGR (2026-2033)

• Market Overview
• Prefilled
• Reusable

Global Smart Insulin Pens Market Size by Product & CAGR (2026-2033)

• Market Overview
• Smart Insulin Pen
• Adaptors for Conventional Pen

Global Smart Insulin Pens Market Size by Connectivity Type & CAGR (2026-2033)

• Market Overview
• Bluetooth
• USB

Global Smart Insulin Pens Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Smart Insulin Pens Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings

Global Smart Insulin Pens Market Size & CAGR (2026-2033)

• North America (Type, Usability, Product, Connectivity Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Usability, Product, Connectivity Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Usability, Product, Connectivity Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Usability, Product, Connectivity Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Usability, Product, Connectivity Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Companion Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digital Medics Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocorp (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emperra GmbH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• E-Health Technologies (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bigfoot Biomedical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pendiq GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DarioHealth Corp. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations